AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAY 6 - (NewsRx.com & NewsRx.net) -- Sentinel node biopsy in breast cancer patients avoids axillary dissection.
According to recent research from Netherlands, "Since its introduction in the early 1990s, the sentinel node (SN) concept in breast cancer has been validated by many studies. Because SN biopsy in breast cancer enables the identification of node-negative axillae, the potential morbidity of an axillary lymph node dissection (ALND) can be avoided."
"The SN procedure is still surrounded by many variables and uncertainties, such as the clinical relevance of micrometastases. However, the main goal is to avoid unnecessary ALND in node-negative breast cancer patients. Sufficient clinical data are available to achieve this goal by incorporating the SN procedure into routine clinical practice," wrote H. Torrenga and colleagues, Vrije University of Amsterdam, Medical Center.
The researchers concluded: "The ultimate safety of the applied technique will be determined by the number of axillary recurrences ...
Source: HighBeam Research, Sentinel node biopsy in breast cancer patients avoids axillary...